← Back to guidelines
Cardiology79 papers

Neonatal lupus erythematosus

Last edited: 4/14/2026

Overview

Neonatal lupus erythematosus (NLE) is a rare condition caused by transplacental passage of maternal autoantibodies, primarily anti-Ro/SSA and anti-La/SSB, leading to various clinical manifestations including cutaneous lesions, hepatobiliary disease, cytopenias, and severe cardiac complications such as congenital heart block 167.

Diagnosis

  • Key Clinical Features: Cutaneous lesions, hepatobiliary disease, cytopenias, congenital heart block 16.
  • Laboratory Tests: Detection of maternal and neonatal anti-Ro/SSA and anti-La/SSB antibodies 1611.
  • Imaging: Cerebral ultrasound may reveal subependymal pseudocysts and hemorrhage, though not correlated with autoantibody levels 2.
  • Histopathology: Direct immunofluorescence showing immunoglobulins and complement at the basement membrane zone in lesional skin 8.
  • Management

  • Supportive Care: Focus on managing specific manifestations (e.g., cardiac support for heart block, hematological support for cytopenias) 15.
  • No Specific Antiviral/Immunosuppressive Therapy: No evidence supports specific antiviral or immunosuppressive treatments beyond supportive care 135.
  • Monitoring: Regular follow-up for neurological and cardiac outcomes, especially in cases of congenital heart block 10.
  • Special Populations

  • Pregnancy: Mothers with anti-Ro/SSA and anti-La/SSB antibodies have a risk of <1 in 50 for having a child with congenital heart block 3.
  • Pediatrics: Neonatal manifestations typically resolve with clearance of maternal antibodies, but severe cases like liver failure can be fatal 5.
  • Key Recommendations

  • Screen Pregnant Women for Anti-Ro/SSA and Anti-La/SSB Antibodies to identify risk for neonatal lupus erythematosus (Evidence: Moderate 311).
  • Monitor Affected Infants Closely for Cardiac and Neurological Complications, particularly congenital heart block and cerebral ultrasound anomalies (Evidence: Moderate 210).
  • Provide Supportive Care Tailored to Specific Manifestations (e.g., cardiac support, hematological management) (Evidence: Expert opinion 15).
  • References

    1 Vanoni F, Lava SAG, Fossali EF, Cavalli R, Simonetti GD, Bianchetti MG et al.. Neonatal Systemic Lupus Erythematosus Syndrome: a Comprehensive Review. Clinical reviews in allergy & immunology 2017. link 2 Zuppa AA, Gallini F, De Luca D, Luciano R, Frezza S, de Turris PL et al.. Cerebral ultrasound findings in neonatal lupus syndrome. Biology of the neonate 2004. link 3 Buyon JP, Rupel A, Clancy RM. Neonatal lupus syndromes. Lupus 2004. link 4 Brucato A, Cimaz R, Stramba-Badiale M. Neonatal lupus. Clinical reviews in allergy & immunology 2002. link 5 Selander B, Cedergren S, Domanski H. A case of severe neonatal lupus erythematosus without cardiac or cutaneous involvement. Acta paediatrica (Oslo, Norway : 1992) 1998. link 6 Silverman ED, Laxer RM. Neonatal lupus erythematosus. Rheumatic diseases clinics of North America 1997. link70349-5) 7 Tseng CE, Buyon JP. Neonatal lupus syndromes. Rheumatic diseases clinics of North America 1997. link70313-6) 8 Maynard B, Leiferman KM, Peters MS. Neonatal lupus erythematosus syndrome. Journal of cutaneous pathology 1991. link 9 Maddison PJ. The neonatal lupus syndrome. Clinical and experimental rheumatology 1988. link 10 McCune AB, Weston WL, Lee LA. Maternal and fetal outcome in neonatal lupus erythematosus. Annals of internal medicine 1987. link 11 Lee LA, Weston WL. New findings in neonatal lupus syndrome. American journal of diseases of children (1960) 1984. link

    Original source

    1. [1]
      Neonatal Systemic Lupus Erythematosus Syndrome: a Comprehensive Review.Vanoni F, Lava SAG, Fossali EF, Cavalli R, Simonetti GD, Bianchetti MG et al. Clinical reviews in allergy & immunology (2017)
    2. [2]
      Cerebral ultrasound findings in neonatal lupus syndrome.Zuppa AA, Gallini F, De Luca D, Luciano R, Frezza S, de Turris PL et al. Biology of the neonate (2004)
    3. [3]
      Neonatal lupus syndromes.Buyon JP, Rupel A, Clancy RM Lupus (2004)
    4. [4]
      Neonatal lupus.Brucato A, Cimaz R, Stramba-Badiale M Clinical reviews in allergy & immunology (2002)
    5. [5]
      A case of severe neonatal lupus erythematosus without cardiac or cutaneous involvement.Selander B, Cedergren S, Domanski H Acta paediatrica (Oslo, Norway : 1992) (1998)
    6. [6]
      Neonatal lupus erythematosus.Silverman ED, Laxer RM Rheumatic diseases clinics of North America (1997)
    7. [7]
      Neonatal lupus syndromes.Tseng CE, Buyon JP Rheumatic diseases clinics of North America (1997)
    8. [8]
      Neonatal lupus erythematosus syndrome.Maynard B, Leiferman KM, Peters MS Journal of cutaneous pathology (1991)
    9. [9]
      The neonatal lupus syndrome.Maddison PJ Clinical and experimental rheumatology (1988)
    10. [10]
      Maternal and fetal outcome in neonatal lupus erythematosus.McCune AB, Weston WL, Lee LA Annals of internal medicine (1987)
    11. [11]
      New findings in neonatal lupus syndrome.Lee LA, Weston WL American journal of diseases of children (1960) (1984)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG